Rheumatoid arthritis medications and lactation

Area of Science:

• Rheumatology
• Pharmacology
• Neonatal Care

Background:

• Rheumatoid arthritis (RA) patients often experience disease remission during pregnancy.
• Postpartum RA flares are common and challenging to manage due to medication transfer into breast milk.
• Breastfeeding offers significant benefits, necessitating careful medication management for nursing mothers.

Purpose of the Study:

• To review commonly used RA medications for safety during lactation.
• To guide rheumatologists in adjusting postpartum RA therapy to permit breastfeeding.
• To summarize available data on antirheumatic drug transfer into breast milk.

Main Methods:

• Review of existing literature on RA medication use during lactation.
• Analysis of drug transfer levels into breast milk and infant sera.
• Categorization of RA drugs based on breastfeeding safety.

Main Results:

• NSAIDs (shorter-acting preferred) and prednisone (with timing considerations) are generally safe.
• Hydroxychloroquine, sulfasalazine, cyclosporine, azathioprine (AZA), and TNF-α inhibitors show low infant exposure.
• Methotrexate and leflunomide are contraindicated; other biologics lack data and should be avoided.

Conclusions:

• Several RA medications can be used during lactation with minimal infant risk.
• Methotrexate and leflunomide are not recommended for breastfeeding mothers.
• Informed medication choices are crucial for managing postpartum RA while supporting breastfeeding.